GSK Jumps On Hiked 2025 Outlook, But CEO Remains 'Very Cautious' About Vaccines

Published 1 week ago Positive
GSK Jumps On Hiked 2025 Outlook, But CEO Remains 'Very Cautious' About Vaccines
Auto

Related Stocks

G1SK34.SA GSK plc
GSK stock rose early Wednesday on strong 2025 guidance on the back of its third-quarter sales and earnings beat.

Continue Reading

View Comments

More News

FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

29 minutes ago Positive

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages WPP plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - WPP

41 minutes ago Positive

Earnings Scorecard: 6 out of 10 energy firms deliver EPS wins this week

51 minutes ago Positive

The 1 Number That Shows Why Alphabet Is a Buy Today

55 minutes ago Positive

Onto Innovation (ONTO): Reassessing Valuation After Analyst Upgrades and New Growth Guidance

1 hour ago Positive